CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicentre Primary & Booster Vaccination Study of GSK Biologicals' Hib-MenCY-TT Conjugate Vaccine vs ActHIB® & MenC Conjugate Licensed Vaccine When Given According to the 2-4-6 Month Schedule to Healthy Infants With Booster Dose at 12 to 15 Months

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00134719
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:52.001610+00:00
Published At: 2012-07-20T00:00:00+00:00
Record Updated At: 2018-07-19
Results Posted At: 2012-07-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neisseria Meningitidis", "Haemophilus Influenzae Type b"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-07-19"
protocolSection.identificationModule.nctId: "NCT00134719"
protocolSection.identificationModule.officialTitle: "A Multicentre Primary \u0026 Booster Vaccination Study of GSK Biologicals\u0027 Hib-MenCY-TT Conjugate Vaccine vs ActHIB\u00ae \u0026 MenC Conjugate Licensed Vaccine When Given According to the 2-4-6 Month Schedule to Healthy Infants With Booster Dose at 12 to 15 Months"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2012-07-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.